Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Translational Lung Cancer Research|January 25, 2021
A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active playerYue Zhou, Fan Yu, Yang Zhao, et al.
Food & Function|December 1, 2018
Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activityTiantian Guo, Qingchao Liu, Pengbo Hou, et al.
Nature Materials|March 28, 2026
Mineral-originated bioelectronics for inhibition via lithium electrochemistryZhe Cheng, Tiantian Guo, Gangbin Yan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation TherapyTiantian Guo, Jianjiao Ni, Xi Yang, et al.
Virulence|October 17, 2018
Porcine transmissible gastroenteritis virus nonstructural protein 2 contributes to inflammation via NF-κB activationLi Wang, Xinyuan Qiao, Sijia Zhang, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2023
Association of BMI with mortality in drug-induced liver injuryZikun Ma, Min Li, Yan Wang, et al.
Histopathology|October 2, 2014
Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancerTianTian Guo, YingNan Yu, George Wai-Cheong Yip, et al.
The British Journal of Radiology|May 25, 2022
Clinical value of PET/CT in identifying patients with oligometastatic/oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisonsDayu Xu, Fan Yu, Tiantian Guo, et al.
Clinical and Translational Radiation Oncology|September 8, 2025
Prognostic factors, patterns of failure and re-irradiation in hypofractionated stereotactic radiotherapy-treated brain metastases from non-small cell lung cancerDayu Xu, Yechun Pang, Jinghan Qu, et al.
Eclinicalmedicine|October 14, 2024
Safety and efficacy of consolidative stereotactic radiotherapy for oligo-residual EGFR-mutant non-small cell lung cancer after first-line third-generation EGFR-tyrosine kinase inhibitors: a single-arm, phase 2 trialYue Zhou, Lin Peng, Fei Liang, et al.
Pageof 18